Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Oncoimmunology|August 16, 2019
Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinomaPhilippe Rochigneux, Jean-Charles Nault, Françoise Mallet, et al.
Journal of Medical Virology|July 20, 2024
Protective role of macrophages from maternal-fetal interface in unvaccinated coronavirus disease 2019 pregnant womenLaetitia Gay, Sandra Madariaga Zarza, Perla Abou Atmeh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cellsFlorent Amatore, Nicolas Ortonne, Marc Lopez, et al.
Cancer Immunology Research|September 20, 2024
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell PyroptosisAnne-Charlotte Le Floch, Caroline Imbert, Nicolas Boucherit, et al.
Cell Reports|May 24, 2016
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell ReceptorZsolt Sebestyen, Wouter Scheper, Anna Vyborova, et al.
Cell Reports|October 9, 2025
BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cellsEmilien Billon, Caroline Imbert, Damien Bruyat, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient recordsMathilde Beaufils, Vincent Amodru, Manuel Tejeda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Cancer Immunology Research|January 31, 2025
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical CancerLaurent Gorvel, Marylou Panouillot, Marie-Sarah Rouvière, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Oncoimmunology|August 16, 2019
Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinomaPhilippe Rochigneux, Jean-Charles Nault, Françoise Mallet, et al.
Journal of Medical Virology|July 20, 2024
Protective role of macrophages from maternal-fetal interface in unvaccinated coronavirus disease 2019 pregnant womenLaetitia Gay, Sandra Madariaga Zarza, Perla Abou Atmeh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cellsFlorent Amatore, Nicolas Ortonne, Marc Lopez, et al.
Cancer Immunology Research|September 20, 2024
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell PyroptosisAnne-Charlotte Le Floch, Caroline Imbert, Nicolas Boucherit, et al.
Cell Reports|May 24, 2016
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell ReceptorZsolt Sebestyen, Wouter Scheper, Anna Vyborova, et al.
Cell Reports|October 9, 2025
BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cellsEmilien Billon, Caroline Imbert, Damien Bruyat, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient recordsMathilde Beaufils, Vincent Amodru, Manuel Tejeda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Cancer Immunology Research|January 31, 2025
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical CancerLaurent Gorvel, Marylou Panouillot, Marie-Sarah Rouvière, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Pageof 28